Angelo Sparaneo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Top Venues

Journal of personalized medicine

Future oncology (London, England)

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Antonella Centonza, Tommaso Mazza, Domenico Trombetta, Angelo Sparaneo, Francesco Petrizzelli, Stefano Castellana, Flavia Centra, Federico Pio Fabrizio, Concetta Martina Di Micco, Federica Benso, Fabrizio Tabbò, Luisella Righi, Alessandra Merlini, Paolo Graziano, Lucia Anna Muscarella
Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer. Journal of personalized medicine 14 (7) (2024)
Federico Pio Fabrizio, Angelo Sparaneo, Giusy Gorgoglione, Pierpaolo Battista, Flavia Centra, Francesco Delli Muti, Domenico Trombetta, Antonella Centonza, Paolo Graziano, Antonio Rossi, Vito Michele Fazio, Lucia Anna Muscarella
Effects of KEAP1 Silencing on NRF2 and NOTCH Pathways in SCLC Cell Lines. Cancers 16 (10) (2024)
Antonella Centonza, Tommaso Mazza, Domenico Trombetta, Angelo Sparaneo, Francesco Petrizzelli, Stefano Castellana, Flavia Centra, Federico Pio Fabrizio, Concetta Martina Di Micco, Federica Benso, Fabrizio Tabbò, Luisella Righi, Alessandra Merlini, Paolo Graziano, Lucia Anna Muscarella
Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer. Journal of personalized medicine 14 (7) (2024)
Antonella Centonza, Tommaso Mazza, Domenico Trombetta, Angelo Sparaneo, Francesco Petrizzelli, Stefano Castellana, Flavia Centra, Federico Pio Fabrizio, Concetta Martina Di Micco, Federica Benso, Fabrizio Tabbò, Luisella Righi, Alessandra Merlini, Paolo Graziano, Lucia Anna Muscarella
Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer. Journal of personalized medicine 14 (7) (2024)
Federico Pio Fabrizio, Angelo Sparaneo, Giusy Gorgoglione, Pierpaolo Battista, Flavia Centra, Francesco Delli Muti, Domenico Trombetta, Antonella Centonza, Paolo Graziano, Antonio Rossi, Vito Michele Fazio, Lucia Anna Muscarella
Effects of KEAP1 Silencing on NRF2 and NOTCH Pathways in SCLC Cell Lines. Cancers 16 (10) (2024)
Lucia Anna Muscarella, Tommaso Mazza, Federico Pio Fabrizio, Angelo Sparaneo, Vito D'Alessandro, Antonio Tancredi, Domenico Trombetta, Flavia Centra, Silvana Pia Muscarella, Concetta Martina Di Micco, Antonio Rossi
Neuroendocrine-Related Circulating Transcripts in Small-Cell Lung Cancers: Detection Methods and Future Perspectives. Cancers 13 (6) (2021)
Domenico Trombetta, Angelo Sparaneo, Lucia Anna Muscarella
NRG fusions in tumors: moving from the past to future knowledge. Future oncology (London, England) 17 (5) (2021)
Federico Pio Fabrizio, Domenico Trombetta, Antonio Rossi, Angelo Sparaneo, Stefano Castellana, Lucia Anna Muscarella
Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy. Therapeutic advances in medical oncology 10 (2018)